Stephanie O'Brien

Insider Reports History

Entity
Individual
Location
C/O Morningside Technology Advisory, Llc, 1188 Centre Street, Newton Centre, MA
Signature
/s/ David Watson, attorney-in-fact for Stephanie O'Brien
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephanie O'Brien:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. Director Common Stock 11.4K $728K $63.69 Jan 1, 2024 Direct
Apellis Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 5.75K $381K $66.30 Jan 1, 2024 Direct

Insider Reports Filed by Stephanie O'Brien

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2024 2 $344K 4 Jan 2, 2024 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2023 2 $0 4 Jan 4, 2023 Director
APLS Apellis Pharmaceuticals, Inc. Jan 1, 2022 2 $0 4 Jan 4, 2022 Director